Zhu X - Search Results

1

MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.

Fang Y, Zhu X, Wang J, Li N, Li D, Sakib N, Sha Z, Song W. Fang Y, et al. Among authors: zhu x. Oncotarget. 2015 May 30;6(15):13164-75. doi: 10.18632/oncotarget.3754. Oncotarget. 2015. PMID: 25961434 Free PMC article.

2

MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells.

Zhu X, Zhang X, Wang H, Song Q, Zhang G, Yang L, Geng J, Li X, Yuan Y, Chen L. Zhu X, et al. Oncol Rep. 2012 Jul;28(1):218-24. doi: 10.3892/or.2012.1770. Epub 2012 Apr 20. Oncol Rep. 2012. PMID: 22576802

3

MTA1 contributes to actin cytoskeleton reorganization and metastasis of nasopharyngeal carcinoma by modulating Rho GTPases and Hedgehog signaling.

Song Q, Li Y, Zheng X, Fang Y, Chao Y, Yao K, Zhu X. Song Q, et al. Among authors: zhu x. Int J Biochem Cell Biol. 2013 Jul;45(7):1439-46. doi: 10.1016/j.biocel.2013.04.017. Epub 2013 Apr 22. Int J Biochem Cell Biol. 2013. PMID: 23618874

4

MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b.

Li Y, Chao Y, Fang Y, Wang J, Wang M, Zhang H, Ying M, Zhu X, Wang H. Li Y, et al. Among authors: zhu x. J Exp Clin Cancer Res. 2013 May 29;32(1):33. doi: 10.1186/1756-9966-32-33. J Exp Clin Cancer Res. 2013. PMID: 23718732 Free PMC article.

5

MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo.

Song Q, Zhang H, Wang M, Song W, Ying M, Fang Y, Li Y, Chao Y, Zhu X. Song Q, et al. Among authors: zhu x. J Exp Clin Cancer Res. 2013 Aug 14;32(1):54. doi: 10.1186/1756-9966-32-54. J Exp Clin Cancer Res. 2013. PMID: 23941622 Free PMC article.

6

[Risk factors of level Ib lymphadenopathy in nasopharyngeal carcinoma].

Yuan G, Zheng X, Zhu X, Wang Z, Song W, Zhang H, Sha Z. Yuan G, et al. Among authors: zhu x. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(7):983-7. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 25057069 Chinese.

7

Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis.

Ying M, Zhu X, Chen K, Sha Z, Chen L. Ying M, et al. Among authors: zhu x. J Cancer Res Clin Oncol. 2015 Aug;141(8):1427-39. doi: 10.1007/s00432-015-1910-9. Epub 2015 Jan 11. J Cancer Res Clin Oncol. 2015. PMID: 25577224

8

miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.

Zhang H, Zhu X, Li N, Li D, Sha Z, Zheng X, Wang H. Zhang H, et al. Among authors: zhu x. Acta Biochim Biophys Sin (Shanghai). 2015 Jul;47(7):496-503. doi: 10.1093/abbs/gmv039. Epub 2015 May 21. Acta Biochim Biophys Sin (Shanghai). 2015. PMID: 25998575 Free article.

9

KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials.

Ying M, Zhu XX, Zhao Y, Li DH, Chen LH. Ying M, et al. Asian Pac J Cancer Prev. 2015;16(10):4439-45. doi: 10.7314/apjcp.2015.16.10.4439. Asian Pac J Cancer Prev. 2015. PMID: 26028111 Free article. Review.

10

Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism.

Sha Z, Zhu X, Li N, Li Y, Li D. Sha Z, et al. Among authors: zhu x. Oncotarget. 2016 Oct 4;7(40):64977-64986. doi: 10.18632/oncotarget.11285. Oncotarget. 2016. PMID: 27533465 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,047 results

Search Page

Filters